NovaBridge Biosciences (NBP) EPS (Basic) (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly EPS (Basic) of -$0.33 for Q4 2025, down 547.71% year-on-year from $0.07 in Q4 2024, and down 893.56% on a QoQ basis from -$0.03 in Q3 2025.
NovaBridge Biosciences (NBP) EPS (Basic) (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported EPS (Basic) for 5 consecutive years, with -$0.33 the latest figure, recorded in Q4 2025.
- Quarterly EPS (Basic) fell 547.71% year-over-year to -$0.33 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.4 (down 450.96% YoY) and the FY2024 annual result came in at $0.15, up 113.64% from the prior year.
- EPS (Basic) eased to -$0.33 in Q4 2025 per NBP's latest filing, from -$0.03 in the prior quarter.
- Over the last five years, EPS (Basic) for NBP reached as high as $0.17 in Q3 2023 and fell as low as -$0.33 in Q4 2025.
- A 3-year average of -$0.03 and a median of -$0.02 in 2025 frame the typical range for EPS (Basic).
- The largest YoY upside for EPS (Basic) was 69.7% in 2025 against a maximum downside of 4193524.42% in 2025.
- Year by year, EPS (Basic) stood at $0.17 in 2023, then plunged by 57.14% to $0.07 in 2024, then slumped by 547.71% to -$0.33 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.33, -$0.03, and -$0.03 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | -0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | -0.03 |
| Jun 30, 2025 | -0.03 |
| Mar 31, 2025 | -0.02 |
| Dec 31, 2024 | 0.07 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -0.04 |
| Sep 30, 2023 | 0.17 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2020 | 1.17 |
| Sep 30, 2020 | -0.65 |
| Dec 31, 2019 | -7.34 |
| Sep 30, 2019 | -4.89 |